Pregnancy loss burden as a potential effect modifier of intravenous immunoglobulin effect on live birth in recurrent pregnancy loss: A secondary individual patient data meta-analysis
Authors:
- Louise KofodLKLouise Kofod
- Rasmus WaagepetersenRWRasmus Waagepetersen
- Ole Bjarne ChristiansenOCOle Bjarne Christiansen
- Ulrik Schiøler KesmodelUKUlrik Schiøler Kesmodel
Open Access
- 3 November 2026
- journal article
- review article
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 178
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Intravenous immunoglobulin versus placebo in recurrent pregnancy loss: A systematic review and meta-analysis of randomized trialsJournal of Reproductive Immunology, 2025
- Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy lossAmerican Journal of Reproductive Immunology, 2023
- Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trialeClinicalMedicine, 2022
- Recurrent pregnancy loss: fewer chromosomal abnormalities in products of conception? a meta-analysisJournal of Assisted Reproduction and Genetics, 2022
- Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double‐blind, placebo‐controlled trialBJOG: An International Journal of Obstetrics & Gynaecology, 2014
- A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriageHuman Reproduction, 2002
- Embryonic karyotype of abortuses in relation to the number of previous miscarriagesFertility and Sterility, 2000
- Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled studyHuman Reproduction, 1999
- Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian studyHuman Reproduction, 1997
- Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulinHuman Reproduction, 1995